Figure 3. (a) N-H stretching region of the infrared spectra for
5.4 mM CHCl3 solution of 1 (red line) and 11.2 mM CHCl3 solution
of 2 (blue line). (b) Chemical structure of model cavitand 3.
counted the possibility of intermolecular aggregation. The
observed diffusion coefficients of 1 remained almost a
constant value of (5 ( 2) × 10-6 cm2 s-1 for concentrations
of 0.7-6.9 mM of 1 in CDCl3.9 The VPO measurements,
3.0-8.9 mM CDCl3 solutions of 1, showed that the observed
molecular weight (Mwobs ) 1210 ( 120) is about 50% lower
than the value calculated for the monomeric 1 (Mw ) 2339).
The discrepancy is significant; however, additional experi-
ments with model compounds were consistent in showing
nonideal behavior of this class of molecules.10 The 1H NMR
spectrum of 1 at 328 K revealed a set of well-defined
resonances corresponding to a molecule with average C4
symmetry (Figure 2a). At 258 K, however, each resonance
was clearly split into two signals with equal intensities, so
Figure 1. Chemical structures of cavitand 1 and model compound
2. Energy minimized (AMBER) enantiomeric forms 1a and 1b of
C2 symmetrical 1 as vase-like conformers.
Cavitand 1 was designed to contain four identical pyrazine-
based “flaps”, with each flap having a benzene unit func-
tionalized with an acetamide and a methoxy group (Figure
1). The acetamides were predisposed to act as donors (but
may also be acceptors!) and the methoxy groups as acceptors
of hydrogen bonding, so that 1 can develop a vase-like
geometry with a seam of intramolecular hydrogen bonds
along its upper rim.5c As the vase structure is maintained
via hydrogen bonding, the pyrazine units were foreseen to
act as basic sites to, upon reacting with an external acid,
promote change in the conformational dynamics of 1.
The preparation of 1 and model compounds 2 and 3
(Figure 3) is described in the Supporting Information. The
(3) (a) Gutsche, C. D.; Bauer, L. J. Tetrahedron Lett. 1981, 22, 4763-
4766. (b) Groenen, L. C.; Van Loon, J. D.; Verboom, W.; Harkema, S.;
Casnati, A.; Ungaro, R.; Pochini, A.; Ugozzoli, F.; Reinhoudt, D. N. J.
Am. Chem. Soc. 1991, 113, 2385-2392. (c) Blixt, J.; Detellier, C. J. Am.
Chem. Soc. 1994, 116, 11957-11960. (d) Ikeda, A.; Shinkai, S. Chem.
ReV. 1997, 97, 1713-1734. (e) Ma, S.; Rudkevich, D. M.; Rebek, J., Jr.
Angew. Chem., Int. Ed. 1999, 38, 2600-2602. (f) Jasat, A.; Sherman, J. C.
Chem. ReV. 1999, 99, 931-967. (g) Naumann, C.; Patrick, B. O.; Sherman,
J. C. Tetrahedron 2002, 4, 787-798. (h) Gibb, C. L. D.; Li, X.; Gibb, B.
C. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 4857-4862. (i) Kang, S.-W.;
Castro, P. P.; Zhao, G.; Nunez, J. E.; Godinez, C. E.; Gutierrez-Tunstad,
L. M. J. Org. Chem. 2006, 71, 1240-1243.
(4) Cram, D. J. Science 1988, 240, 760-767.
(5) (a) Houk, K. N.; Nakamura, K.; Sheu, C.; Keating, A. E. Science
1996, 273, 627-629. (b) Rudkevich, D. M.; Hilmersson, G.; Rebek, J., Jr.
J. Am. Chem. Soc. 1997, 119, 9911-9912. (c) Rudkevich, D. M.;
Hilmersson, G.; Rebek, J., Jr. J. Am. Chem. Soc. 1998, 120, 12216-12225.
(d) Wang, X.; Houk, K. N. Org. Lett. 1999, 1, 591-594. (e) Palmer, L. C.;
Rebek, J., Jr. Org. Biomol. Chem. 2004, 2, 3051-3059.
(6) (a) Hiraoka, S.; Harano, K.; Shiro, M.; Shionoya, M. Angew. Chem.,
Int. Ed. 2005, 44, 2727-2731. (b) Davis, A. V.; Raymond, K. N. J. Am.
Chem. Soc. 2005, 127, 7912-7919. (c) Zuccaccia, D.; Pirondini, L.; Pinalli,
R.; Dalcanale, E.; Macchioni, A. J. Am. Chem. Soc. 2005, 127, 7025-
7032. (d) Davis, A. V.; Fiedler, D.; Seeber, G.; Zahl, A.; Van E. R.;
Raymond, K. N. J. Am. Chem. Soc. 2006, 128, 1324-1333.
(7) (a) Moran, J. R.; Karbach, S.; Cram, D. J. J. Am. Chem. Soc. 1982,
104, 5826-5828. (b) Moran, J. R.; Ericson, J. L.; Dalcanale, E.; Bryant, J.
A.; Knobler, C. B.; Cram, D. J. J. Am. Chem. Soc. 1991, 113, 5707-5714.
(c) Soncini, P.; Bonsignore, S.; Dalcanale, E.; Ugozzoli, E. J. Org. Chem.
1992, 57, 4608-4612.
(8) (a) Skinner, P. J.; Cheetham, A. G.; Beeby, A.; Gramlich, V.;
Diederich, F. HelV. Chim. Acta 2001, 84, 2146-2153. (b) Azov, V. A.;
Diederich, F.; Lill, Y.; Hecht, B. HelV. Chim. Acta 2003, 86, 2149-2155.
(c) Azov, V. A.; Jaun, B.; Diederich, F. HelV. Chim. Acta 2004, 87, 449-
462. (d) Frei, M.; Marotti, F.; Diederich, F. Chem. Commun. 2004, 12,
1362-1363. (e) Lagugne-Labarthet, F.; An, Y. Q.; Yu, T.; Shen, Y. R.;
Dalcanale, E.; Shenoy, D. K. Langmuir 2005, 21, 7066-7070. (f) Azov,
V. A.; Schlegel, A.; Diederich, F. Angew. Chem., Int. Ed. 2005, 44, 4635-
4638.
Figure 2. 1H NMR spectra (500 MHz) of 1 (1.50 mM) in dry
CDCl3 recorded at (a) 328 K, (b) 300 K, and (c) 258 K.
1H NMR spectrum of 1 at 300 K (Figure 2b) showed a set
of broad signals, indicating the existence of either ill-defined
intermolecular aggregates or conformational isomers ex-
1
changing at intermediate rates on the H NMR time scale.
(9) For a review, see: Cohen, Y.; Avram, L.; Frish, L. Angew. Chem.,
Int. Ed. 2005, 44, 520-554.
(10) For further discussion, see Supporting Information.
Diffusion NMR spectroscopy (HR-DOSY) in combination
with vapor pressure osmometry (VPO) measurements dis-
3698
Org. Lett., Vol. 8, No. 17, 2006